Cargando…
Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
Studies on the effective and safe therapeutic dosage of delta-9-tetrahydrocannabinol (THC) for the treatment of Alzheimer’s disease (AD) have been sparse due to the concern about THC’s psychotropic activity. The present study focused on demonstrating the beneficial effect of low-dose THC treatment i...
Autores principales: | Wang, Yanhong, Hong, Yuzhu, Yan, Jiyu, Brown, Breanna, Lin, Xiaoyang, Zhang, Xiaolin, Shen, Ning, Li, Minghua, Cai, Jianfeng, Gordon, Marcia, Morgan, David, Zhou, Qingyu, Cao, Chuanhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910894/ https://www.ncbi.nlm.nih.gov/pubmed/35269905 http://dx.doi.org/10.3390/ijms23052757 |
Ejemplares similares
-
The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
por: Fihurka, Oksana, et al.
Publicado: (2022) -
Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023) -
Delta-8 Tetrahydrocannabinol Product Impurities
por: Ray, Colleen L., et al.
Publicado: (2022) -
Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
por: Shen, Ning, et al.
Publicado: (2019) -
Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women
por: Wardle, Margaret C., et al.
Publicado: (2022)